

			Company registration number:04125947






		ZHI XING TANG CHINESE MEDICAL CENTRE LTD

			FINANCIAL STATEMENTS

			FOR THE YEAR ENDED 30 April 2025



ZHI XING TANG CHINESE MEDICAL CENTRE LTD

BALANCE SHEET

AS AT 30 April 2025


		2025		2024
	Notes	£	£	£	£

FIXED ASSETS
Tangible assets	3		534		628

			534		628

CURRENT ASSETS
Stocks		1,600		1,650
Debtors	4	1,349		1,252
Cash at bank and in hand		827		663

		3,776		3,565

CREDITORS
Amounts falling due within one year	5	(2,981)		(4,022)

NET CURRENT ASSETS			795		(457)

TOTAL ASSETS LESS
CURRENT LIABILITIES			1,329		171


PROVISIONS FOR LIABILITIES			(102)		(120)

NET ASSETS			1,227		51



CAPITAL AND RESERVES
Called-up equity share capital	6		1		1
Profit and loss account			1,226		50

SHAREHOLDERS FUNDS			1,227		51


For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.


The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of the accounts.


These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. Approved by the board of directors on 8 December 2025 and signed on its behalf.


The profit and loss account has not been delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small companies' regime.


..........................................................................
Mrs Jing Wang

8 December 2025
The annexed notes form part of these financial statements.



ZHI XING TANG CHINESE MEDICAL CENTRE LTD

STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 30 APRIL 2025

	Share	Share	P and L	Revaluation	Other	Total
	Capital	Premium	Account	reserve	reserves	equity
	£	£	£	£	£	£
Balance at 1 May 2023	1	0	(1,693)	0	0	(1,692)

Changes in equity
Dividend	0	0	(3,000)	0	0	(3,000)
Total Comprehensive Income	0	0	4,743	0	0	4,743
Balance at 30 April 2024	1	0	50	0	0	51

Changes in equity
Dividend	0	0	(4,300)	0	0	(4,300)
Total comprehensive income	0	0	5,476	0	0	5,476
Balance at 30 April 2025	1	0	1,226	0	0	1,227

ZHI XING TANG CHINESE MEDICAL CENTRE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

Accounting policies

Statutory information

The company is registered in England and its registered number is 04125947. The company is a private company limited by shares. Its registered office is 35B Market Street, Tamworth, Staffordshire, B79 7LR.

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention in accordance with the accounting policies set out below. These financial statements have been prepared in accordance with FRS102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Turnover

Turnover represents sales of goods net of VAT and trade discounts. Turnover is recognised when the goods are physically delivered to the

Fixed Assets

Tangible fixed assets are stated at cost less depreciation. Depreciation i provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Fixtures and Fittings 15% reducing balance basi

Stocks and Work In Progress

Stock is valued at the lower of cost and net realisable value. Cost is determined on a first in first out basis. Net realisable value represents estimated selling price less costs to complete and sell. Provision is made for slow moving, obsolete or damaged stock where the net realisable value is less than cost.

Deferred Taxation

Deferred tax is provided on the liability method to take account of the timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes. Tax deferred or accelerated is accounted for in respect of all material timing differences.

Pension Scheme

The company operates a defined contribution pension scheme, NEST, Standard life, Forester life and Reassure pension scheme, and the pension charge represents the amounts payable by the company to the fund in respect of the year.

Employees

The average number of persons employed by the company (including directors) during the year was 3.



3.	Tangible fixed assets

		F and F	Total

	Cost
	At start of period	3,990	3,990
	At end of period	3,990	3,990

	Depreciation
	At start of period	3,362	3,362
	Provided during the period	94	94
	At end of period	3,456	3,456

	Net Book Value
	At start of period	628	628
	At end of period	534	534



4.	Debtors
		2025	2024
		£	£
	Due within one year
	Prepayments and accrued income	1,349	1,252

		1,349	1,252



5.	Creditors due within one year
		2025	2024
		£	£

	Corporation Tax	488	0
	Other taxes and social security costs	279	279
	Accruals and deferred income	1,961	3,489
	Loan from directors	253	253

		2,981	4,022


6.	Share capital	Alloted, Issued and fully paid
		Alloted, Issued and fully paid
		2025	2024
		£	£

	Ordinary shares of £1 each	1	1
	Total issued share capital	1	1

Pension schemes

The company operates a defined contribution scheme for its employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

Related Party Transactions

There were no related party transaction in which the director has a direct and material interest.